Akari Therapeutics (NASDAQ: AKTX) is pleased to announce that Dr David Horn Solomon will be appointed as the company’s new ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE